Presentation Information
[CMO19-4]Mid-to-Long-Term Outcomes of the Epic Bioprosthesis for Mitral Valve Replacement：Analysis of Mortality Risk Factors and Cumulative Incidence of Structural Valve Deterioration（SVD）
Ryoma Ueda, Senri Miwa, Shunji Kurokawa, Kenji Yamamoto, Sakae Enomoto (Okamura Memorial Hospital)
Password required to view
Comment
To browse or post comments, you must log in.Log in